Live Breaking News & Updates on Kalyanasundaram subramanian

Stay informed with the latest breaking news from Kalyanasundaram subramanian on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Kalyanasundaram subramanian and stay connected to the pulse of your community

Sun Pharma Auditors Deloitte and CJ Goswami & Associates Slapped with Rs3 Lakh Penalty by RoC in Aditya Medisales Issue

Holding Deloitte Haskins & Sells LLP and CJ Goswami & Associates, the secretarial auditor of Sun Pharmaceutical Industries Ltd (Sun Pharma), responsible for not reporting related party transactions of Sun Pharma with its sole distributor and promoter entity Aditya Medisales Ltd, the registrar of companies (RoC) in Gujarat has slapped a penalty of Rs1.50 lakh each on the audit firm and secretarial auditor of the company.

India , Dharmesh-doshi , Sudhir-valia , Kalyanasundaram-subramanian , Sun-pharma , Sailesht-desai , Dilip-shanghvi , Sunil-ajmera , Uday-baldota , Ketan-parekh , Aditya-medisales , Ashoki-bhuta

Sun Pharma Share Price Graph And News

Sun Pharma Share Price Graph And News
stockmaniacs.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockmaniacs.net Daily Mail and Mail on Sunday newspapers.

Bangladesh , India , Hungary , United-kingdom , Israel , Sun-pharma , Rekha-sethi , Vivek-chaand-sehgal , Ashwin-dani , Kekim-mistry , S-mohanchand-dadha , Kalyanasundaram-subramanian

Sun Pharma Officials Including Dilip Shanghvi Settle Case Of Alleged Market Norms Violation With SEBI

BW Businessworld
Sun Pharma, Officials Including Dilip Shanghvi Settle Case Of Alleged Market Norms Violation With SEBI
Sebi had received two whistleblower complaints, wherein allegations were made against Sun Pharmaceutical Industries Ltd (SPIL) and its wholly-owned subsidiary Sun Pharmaceutical Laboratories Ltd (SPLL), alleging that the firms had been diverting funds through its sole distributor in India, Aditya Medisales Ltd.
Photo Credit :
Sun Pharmaceutical Industries Ltd and its senior officials, including Managing Director Dilip Shanghvi, on Thursday settled with regulator Sebi a case pertaining to alleged violation of listing obligation and disclosure requirements norms.
According to separate settlement orders, Sun Pharmaceutical paid over Rs 56.11 lakh towards settlement charges and Shanghvi paid Rs 62.35 lakh.

India , Sun-pharma , Uday-baldota , Sunil-ajmera , Ashoki-bhuta , Kalyanasundaram-subramanian , Sailesht-desai , Sudhirv-valia , Dilip-shanghvi , Aditya-medisales-ltd , Sun-pharmaceutical-laboratories-ltd , Sun-pharmaceutical-industries-ltd

Sun Pharmaceutical Industries Ltd settles whistleblower complaint with Sebi

Sun Pharmaceutical Industries Ltd and its founder Dilip Shanghvi have settled a whistleblower complaint with the Securities and Exchange Board of India (Sebi) alleging diversion of funds through the company’s sole distributor.
Sun Pharma has paid a settlement amount of Rs 56.1 lakh, Shanghvi has paid Rs 62.35 lakh.
Other top executives of the company that included chief financial officer- Uday Baldota (Rs 24.65 lakh), whole time directors Kalyanasundaram Subramanian (Rs 36.9 lakh), Sailesh T. Desai (Rs 37.41 lakh) and Sudhir V. Valia (Rs 37.41 lakh) have also settled the case without admission or denial of guilt before the capital market regulator.
Whistleblower complaints were made against the country’s largest drug maker and its wholly owned subsidiary, Sun Pharmaceutical Laboratories Ltd, alleging that they had been diverting funds through Aditya Medisales Ltd (AML), its sole distributor in India. It was also alleged that transactions with AML were going on for several years.

India , Sun-pharma , Sailesht-desai , Dilip-shanghvi , Sudhirv-valia , Aditya-medisales-ltd , Exchange-board-of-india-sebi , Sun-pharmaceutical-industries-ltd , Sun-pharmaceutical-laboratories-ltd , Exchange-board , Kalyanasundaram-subramanian , Listing-obligation

Sun Pharma, officials including Dilip Shanghvi settle case of alleged market norms violation with SE- The New Indian Express

According to separate settlement orders, Sun Pharmaceutical paid over Rs 56.11 lakh towards settlement charges and Shanghvi paid Rs 62.35 lakh.

India , Kalyanasundaram-subramanian , Uday-baldota , Sailesht-desai , Dilip-shanghvi , Sudhirv-valia , Sunil-ajmera , Ashoki-bhuta , Aditya-medisales-ltd , Sun-pharmaceutical-laboratories-ltd , Sun-pharmaceutical-industries-ltd , Managing-director-dilip-shanghvi

Sun Pharma Beats Estimates In Q3 As Profit Doubles To Rs 1,852.5 Crore

Sun Pharma Beats Estimates In Q3 As Profit Doubles To Rs 1,852.5 Crore
moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.

Sun-pharma , Kalyanasundaram-subramanian , Whole-time-director , சூரியன்-பார்மா , கல்யாணசுந்தரம்-சுப்ரமணியன் , முழு-நேரம்-இயக்குனர் ,